Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02011893 · ClinicalTrials.gov registry record · NA
SUNBURST (Success Using Neuromodulation With BURST) Study
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 173
- Enrollment target
NCT02011893 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 173 participants.
The verdict
NCT02011893, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 173 participants
- Enrollment target
Study Summary
The purpose of the study is to demonstrate the safety and efficacy of the Prodigy system for the treatment of chronic intractable pain of the trunk and/or limbs.
Interventions
- DEVICE Tonic Stimulation
- DEVICE Burst Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2013-12 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02011893
The ClinicalTrials.gov registry entry for NCT02011893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 173 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tonic Stimulation is the first listed.
NCT02011893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02011893 about?
NCT02011893 is a clinical study titled "SUNBURST (Success Using Neuromodulation With BURST) Study". The purpose of the study is to demonstrate the safety and efficacy of the Prodigy system for the treatment of chronic intractable pain of the trunk and/or limbs.
What is the current status of trial NCT02011893?
This trial is currently completed. It is a NA study. The enrollment target is 173 participants. The study started on 2013-12. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02011893?
The interventions under investigation include: Tonic Stimulation (DEVICE), Burst Stimulation (DEVICE).
Who is sponsoring clinical trial NCT02011893?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.